4//SEC Filing
Asterias Biotherapeutics, Inc. 4
Accession 0001209191-14-053723
CIK 0001572552operating
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 7:01 PM ET
Size
6.6 KB
Accession
0001209191-14-053723
Insider Transaction Report
Form 4
LEBKOWSKI JANE
Pres., Research & Development
Transactions
- Other
Series A Common Stock
2014-08-18+476→ 476 total
Holdings
- 400,000
Option to Purchase Series B Common Stock
Exercise: $2.34Exp: 2020-03-09→ Series B Common Stock (400,000 underlying)
Footnotes (3)
- [F1]Shares received from Geron Corporation as part of a distribution to holders of Geron Common Stock.
- [F2]Options pertain to the purchase of Series B common stock. The Series B common stock may be converted into Series A common stock by the company upon the occurrence of certain events, and the options will become exercisable for the purchase of Series A common stock when outstanding Series B common stock is converted into Series A common stock.
- [F3]1/48th of the number of options will vest and become exercisable at the end of each full month of employment after March 10, 2013.
Documents
Issuer
Asterias Biotherapeutics, Inc.
CIK 0001572552
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001572552
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 7:01 PM ET
- Size
- 6.6 KB